University of Zurich

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Zurich</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Zurich, Switzerland</td>
</tr>
<tr>
<td class="label">Type</td>
<td>University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.uzh.ch/" target="_blank">https://www.uzh.ch/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Prion , [Alzheimer's Disease](//alzheimers), [Neuroinflammation](//neuroinflammation)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Institute of Neuropathology</td>
</tr>
</table>

University of Zurich

Overview

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Zurich</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Zurich, Switzerland</td>
</tr>
<tr>
<td class="label">Type</td>
<td>University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.uzh.ch/" target="_blank">https://www.uzh.ch/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>Prion , [Alzheimer's Disease](//alzheimers), [Neuroinflammation](//neuroinflammation)</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Institute of Neuropathology</td>
</tr>
</table>

University of Zurich

Overview

University of Zurich is Switzerland's largest university, located in Zurich, Switzerland["@university2024"]. The institution is home to world-leading research in neurodegenerative , particularly known for pioneering work on prion and neuroinflammation. The Institute of Neuropathology at UZH has been central to understanding the molecular of protein misfolding .

The institution hosts 1 researcher tracked in the NeuroWiki database and maintains 1 department dedicated to neuroscience research["@neurowiki2024"]. The research programs span Prion , Alzheimer's Disease, and Neuroinflammation, contributing to both basic science understanding and translational approaches for neurodegenerative conditions.

History and Milestones

UZH has a distinguished history in neuroscience research, particularly in neurodegeneration.

Key Historical Milestones:

• 1893: University of Zurich founded
• 1970s: Institute of Neuropathology established
• 1990s: Pioneering prion disease research
• 2000s: Leadership in neuroinflammation research
• 2010: Zurich Neuroscience Center established
• 2020: Advanced imaging and AI approaches

Research Programs

Focus Areas

• Prion Diseases
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Neuroinflammation](/mechanisms/neuroin- [Protein Aggregation](/mechanisms/protein-aggregation)Sclerosis
• [Protein Aggregation](/mechanisms/protein-aggregation)

Departments and Centers

• Institute of Neuropathology: Leading neuropathology research
• Zurich Neuroscience Center: Interdisciplinary neuroscience
• Center for Molecular Medicine: Molecular of disease

Research Themes

Prion Research

• Prion protein structure and function
• Mechanism of prion propagation
• Species barriers and strain diversity

Neuroinflammation

• [Microglia](/cell-types/microglia) biology in neurodegeneration
• Inflammatory pathways in AD and PD
• Therapeutic targeting of inflammation

Protein Misfolding

• [Amyloid-beta](/proteins/amyloid-beta) aggregation
• [Tau](/proteins/tau) pathology spreading
• [Alpha-synuclein](/proteins/alpha-synuclein) propagation

Notable Discoveries and Contributions

Prion Diseases

• Prion Protein Structure: Understanding PrPsc formation
• Strain Classification: Novel prion strain definitions
• Diagnostic Methods: Ultrasensitive prion detection

Neuroinflammation

• [Microglia](/cell-types/microglia) Activation: Novel pathways in neurodegeneration
• [TREM2](/proteins/trem2-protein) Biology: Microglial receptors in AD
• Therapeutic Targets: Anti-inflammatory approaches

Biomarkers

• CSF for prion disease
• Inflammatory markers in neurodegeneration
• Novel detection methods

Key Researchers

| Researcher | Focus Areas |
|------------|-------------|
| Adriano Aguzzi | Prion , Neuroinflammation |
| Marie-Thérèse H. Heeusel | Neuropathology |

Funding and Resources

Major Grants

• Swiss National Science Foundation (SNSF)
• EU Framework Programs
• Foundation grants

Research Facilities

• Neuropathology Laboratory: Histopathology and molecular pathology
• Prion Research Center: Specialized prion research
• Imaging Facility: Advanced microscopy

Cross-Links to Related Pages

Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Creutzfeldt-Jakob Disease
• [Prion Diseases](/diseases/prion-diseases)

• Alpha-Sy- [Protein Aggregation](/mechanisms/protein-aggregation)- Neuroinflammation
• Pr
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)s
• Protein Aggregat
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)# Key Publications

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) KEGG Pathways

International Collaborations

UZH maintains European partnerships:

Major Partnerships

• JPND: EU neurodegeneration research
• Swiss National Science Foundation
• DZNE Partnership: German-Swiss collaboration

Future Directions

Emerging Research Areas

• Novel prion therapies: Treatment development
• Microglia biology: Neuroinflammation
• Protein aggregation: Mechanism understanding

Strategic Priorities

Impact and Recognition

Impact

• Fundamental prion discoveries
• Neuroinflammation expertise
• European leadership

Research Infrastructure

Core Facilities

Laboratory

• Molecular Biology: Protein research
• Cell Culture: Cellular models
• Animal Facility: Transgenic models

Imaging

• Microscopy: Advanced imaging
• Histology: Tissue analysis
• Flow Cytometry: Cell sorting

Clinical

• Patient Cohorts: Longitudinal studies
• Clinical Trials: Early-phase studies
• Brain Bank: Tissue collection

Training Programs

Educational Opportunities

Graduate

• PhD in Neuroscience: Doctoral program
• Master's Programs: Research training

Clinical

• Neurology Residency: Clinical training
• Neuropathology Fellowship: Sub-specialty
• Research Fellowships: Postdoctoral

European Integration

EU Networks

• JPND: Neurodegeneration research
• NEURO: European neuroscience
• COST Actions: Collaborative networks

Distinguished Research Programs

Prion Research Excellence

Prion Biology

• Prion Protein Structure: Understanding PrP misfolding
• Strain Diversity: Characterization of different strains
• Species Barriers: Transmission between species
• Therapeutic Approaches: Developing treatments

Prion Disease Program

• Creutzfeldt-Jakob Disease: Sporadic, familial, and iatrogenic CJD
• Variant CJD: UK BSE-related disease
• Animal Prion Diseases: Scrapie, BSE, chronic wasting disease
• Cellular Models: In vitro disease modeling

Research Methodology

Neuroinflammation

Microglia Research

• TREM2 Biology: Microglial receptor in AD
• Inflammatory Pathways: NF-κB, inflammasome
• Phagocytosis: Clearance of pathological
• Neuroprotection: Beneficial inflammation

Glia-Neuron Interactions

• Astrocyte Biology: Support cell functions
• Oligodendrocyte: Myelin in neurodegeneration
• Blood-Brain Barrier: Vascular contributions

Clinical Programs

Patient Care

Prion Disease Clinic

• Diagnostic Workup: Including brain biopsy
• Supportive Care: Symptom management
• Clinical Trials: When available
• Family Counseling: Genetic counseling

Training and Collaboration

European Networks

JPND (EU Joint Programme - Neurodegenerative Disease Research)

• Research Coordination: European collaboration
• Funding Programs: Joint grant initiatives
• Data Sharing: Collaborative databases

DZNE Partnership

• Joint Projects: Cross-border research
• Clinical Trials: Multi-site studies
• Training: Exchange programs

Distinguished Research Programs

Neurodegeneration Research

Alzheimer's Disease Program

• Amyloid Biology: Understanding Aβ aggregation
• Tau Pathology: Mechanisms of tau spreading
• Neuroinflammation: Microglial contributions
• Therapeutic Development: Drug discovery

Parkinson's Disease Research

• Alpha-Synuclein: Aggregation
• LRRK2 Biology: Common genetic risk factor
• Dopaminergic Neurons: Cell death
• Therapeutic Targets: Novel treatments

Research Infrastructure

Laboratory Facilities

Molecular Biology

• Protein Expression: Recombinant
• Protein Purification: Biochemical characterization
• Biophysical Methods: Aggregation analysis

Cell Biology

• Cell Culture: Neuronal and glial cultures
• Primary Neurons: Primary cell models
• Stem Cells: iPSC-derived neurons

Animal Models

• Transgenic Mice: Disease models
• Behavior Testing: Cognitive and motor assays
• In Vivo Imaging: Live animal imaging

Clinical Research

Clinical Trials

Early-Phase Trials

• First-in-Human: Testing novel compounds
• Safety Studies: Phase I trials
• Dose-Finding: Phase II studies

Investigator-Initiated

• Academic Trials: Researcher-initiated studies
• Biomarker Studies: Validation projects
• Observational Studies: Natural history

Swiss Research Excellence

National Collaboration

Swiss National Science Foundation

• Project Grants: Research funding
• Career Funding: Fellowships and awards
• Infrastructure: Core facilities

Zurich Neuroscience Network

• Joint Seminars: Regular meetings
• Shared Resources: Core facilities
• Student Exchange: Training opportunities

See Also

• [//overview|Cell Types Overview](/content/cell-types)
• [Gene Overview](/genes)
• [//overview|Disease Overview](/diseases/neurodegeneration)

References